Catechol-binding serines of β2-adrenergic receptors control the equilibrium between active and inactive receptor states

Molecular Pharmacology

Volumn 57, Issue 1, 2000, Pages 198-210

  Ambrosio, Caterlna ^a   Molinari, Paola ^a   Cotecchia, Susanna ^b   Costa, Tommaso ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; CATECHOL; SERINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

AMINO ACID SUBSTITUTION; ANIMALS; CATECHOLS; CLONING, MOLECULAR; COS CELLS; GENE DELETION; HYDROXYLATION; LIGANDS; MUTAGENESIS; RECEPTORS, ADRENERGIC, BETA-2; SERINE; SIGNAL TRANSDUCTION; THERMODYNAMICS;

EID: 0033971119     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Boresch S and Karplus M (1994) The meaning of component analysis: Decomposition of the free energy in terms of specific interactions, J Mol Biol 254:801-807.
2. Cavalli A, Fanelli F, Taddei C, De Benedetti PG and Cotecchia S (1996) Amino acids of the alpha 1B-adrenergic receptor involved in agonist binding: Differences in docking catecholamines to receptor subtypes. FEBS Lett 399:9-13.
3. Cotecchia S, Exum S, Caron MG and Lefkowitz RJ (1990) Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA 87:2896-2900.
4. DeLean A, Munson PJ and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol 235:E97-E102.
5. DeLean A. Stadel JM and Lefkowitz RJ (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor J Biol Chem 255:7108-7117.
6. Dill KA (1997) Additivity principles in biochemistry. J Biol Chem 272:701-704.
7. Faiman GA and Horovitz A (1996) On the choice of reference mutant states in the application of the double-mutant cycle method. Protein Eng 9:315-316.
8. Gether U, Ballesteros JA, Seifert R, Sanders-Bush E, Weinstein H, Kobilka BK (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272:2587-2590.
9. Hidalgo P and MacKinnon R (1995) Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor. Science (Wash DC) 268:307-310.
10. Horovitz A (1987) Non additivity in protein-protein interactions. J Mol Biol 196: 733-735.
11. Horovitz A and Fersht AR (1990) Strategy for analyzing the cooperativity of intramolecular interactions in peptides and proteins. J Mol Biol 214:613-617.
12. Hwa J and Ferez DM (1996) The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation. J Biol Chem 271:6322-6327.
13. Kikkawa H, Isogaya M, Nagao T and Kurose H (1998) The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005. Mol Pharmacol 53:128-134.
14. Kikkawa H, Kurose H, Isogaya M, Sato Y and Nagao T (1997) Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists. Br J Pharmacol 121:1059-1064.
15. Kjelsberg MA, Cotecchia S, Ostrowski J, Caron M. G and Lefkowitz RJ (1992) Constitutive activation of the α1B-adrenergic receptor by all amino acid substitutions at a single site. J Biol Chem 267:1430-1433.
16. Lefkowitz RJ, Cotecchia S, Samama P and Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
17. Lefkowitz RJ, Mullikin D and Caron MG (1976) Regulation of beta-adrenergic receptors by guanyl-5′-yl imidodiphosphate and other purine nucleotides. J Biol Chem 251:4686-4692.
18. Link R, Daunt D, Barsh G, Chruscinski A and Kobilka B (1992) Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. Mol Pharmacol 42:16-27.
19. Mark AE and van Gusteren WF (1994) Decomposition of the free energy of a system in terms of specific interactions. Implications for theoretical and experimental studies. J Mol Biol 240:167-176.
20. Munson PJ and Rodbard D (1980) Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
21. Onaran HO and Costa T (1997) Ann NY Acad Sci 812:98-115.
22. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature (Lond) 365:649-651.
23. Perrin CL and Nielson JB (1997) "Strong" hydrogen bonds in chemistry and biology. Annu Rev Phys Chem 48:511-544.
24. Samama P, Cotecchia S, Costa T and Lefkowitz RJ (1993) A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4636.
25. Scheer A, Fanelli F, Costa T, De Benedetti PG and Cotecchia S (1996) Constitutively active mutants of the α1-adrenergic receptor: Role of highly conserved polar amino acids in receptor activation. EMBO J 15:3566-3578.
26. Scheer A, Fanelli F, Costa T, De Benedetti PG and Cotecchia S (1997) The activation process of the α1B-adrenergic receptor: Potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 94:808-813.
27. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T and Cutler GB Jr (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature (Lond) 365:652-654.
28. Strader CD, Candelore MR, Hill WS, Sigal IS and Dixon RA (1989) Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. J Biol Chem 264:13572-13578.
29. Strader CD, Sigal IS, Candelore MR, Rands E, Hill WS and Dixon RA (1988) Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. J Biol Chem 263:10267-10271.
30. Strader CD, Sigal IS, Register RB, Candelore MR, Rands E and Dixon RA (1987) Identification of residues required for ligand binding to the beta-adrenergic receptor. Proc Natl Acad Sci USA 84:4384-4388.
31. Vachon L, Costa T and Herz A (1987) GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells. Mol Pharmacol 31:159-168.
32. 2-A-adrenergic receptors: Identification of amino acids involved in ligand binding and receptor activation by agonists. Mol Pharmacol 40:168-179.
33. Weber G (1972) Ligand binding and internal equilibria in proteins. Biochemistry 11:864-878.
34. Weber G (1973) Energetics of ligand binding to proteins. Adv Protein Chem 29:1-83.